CD274 and ovarian carcinoma: Another spliceosome modulator Pladienolide B, promotes cytotoxic immune cell infiltration and upregulates the expression of PD-L1, augmenting anti-tumor response in ovarian cancer [199] and providing preclinical evidence for the combination’s efficacy in ovarian cancer treatment.